NCCN Guidelines Insights: Antiemesis, Version 2.2017

Authors: Michael J. Berger PharmD, BCOP 1 , David S. Ettinger MD 1 , Jonathan Aston PharmD, BCOP, BCPS 1 , Sally Barbour PharmD, BCOP 1 , Jason Bergsbaken PharmD, BCOP 1 , Philip J. Bierman MD 1 , Debra Brandt DO 1 , Dawn E. Dolan PharmD, BCOP 1 , Georgiana Ellis MD 1 , Eun Jeong Kim PharmD, MS 1 , Steve Kirkegaard PharmD 1 , Dwight D. Kloth PharmD, BCOP 1 , Ruth Lagman MD, MPH, MBA 1 , Dean Lim MD 1 , Charles Loprinzi MD 1 , Cynthia X. Ma MD, PhD 1 , Victoria Maurer MSN, OCN, RN 1 , Laura Boehnke Michaud PharmD, BCOP 1 , Lisle M. Nabell MD 1 , Kim Noonan MS, ANP, AOCN, RN 1 , Eric Roeland MD 1 , Hope S. Rugo MD 1 , Lee S. Schwartzberg MD 1 , Bridget Scullion PharmD, BCOP 1 , John Timoney PharmD, BCOP 1 , Barbara Todaro PharmD 1 , Susan G. Urba MD 1 , Dorothy A. Shead MS 1 and Miranda Hughes PhD 1
View More View Less
  • 1 From The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Vanderbilt-Ingram Cancer Center; Duke Cancer Institute; University of Wisconsin Carbone Cancer Center; Fred & Pamela Buffett Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Moffitt Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; Fox Chase Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; City of Hope Comprehensive Cancer Center; Mayo Clinic Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; UC San Diego Moores Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; and National Comprehensive Cancer Network.
Restricted access

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 243 KB)
All Time Past Year Past 30 Days
Abstract Views 7 0 0
Full Text Views 12683 7490 1489
PDF Downloads 3076 1732 144
EPUB Downloads 0 0 0